Trial Profile
Safety and efficacy of simeprevir and second generation protease inhibitor combination therapy compared with telaprevir in chronic hepatitis C patients.
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 09 Dec 2015
Price :
$35
*
At a glance
- Drugs Simeprevir (Primary) ; Telaprevir (Primary) ; Peginterferon; Ribavirin
- Indications Hepatitis C
- Focus Adverse reactions; Therapeutic Use
- 09 Dec 2015 New trial record